HOME >> MEDICINE >> NEWS
Leading advocates express support for microbicide research, despite disappointing trial results

HIV prevention advocates from three major civil society organizations today emphasized the importance of continued research into new HIV prevention options, despite the recent discontinuation of the Phase III effectiveness trials of the microbicide candidate, cellulose sulfate (CS).

CS was one of the four microbicide candidates in Phase III effectiveness trials for prevention of HIV and other sexually transmitted infections. CONRAD, a reproductive health research organization, was conducting Phase III trials to assess its effectiveness in Benin, India, South Africa, and Uganda. Another Phase III trial of CS sponsored by Family Health International was underway in Nigeria. Both sponsors are not-for profit research groups dedicated to advancing health in developing countries.

At the recommendation of their respective Data Safety Monitoring Boards both sponsors chose to discontinue their CS trials after findings from the CONRAD trial suggested that CS might be contributing to an increased risk of HIV infection. Although review of the data from the Nigerian trial found no evidence of increased risk, FHI felt that the only responsible course of action was to halt its study also.

"Of course we wish the results had been different, but learning what doesn't work can be just as important to progress as learning what does work," observed Lori Heise, Director of the Global Campaign for Microbicides (GCM). "It's also reassuring that the independent Data Safety and Monitoring Committees, put in place to identify problems early on in a trial, appear to have worked well. Advocates have been instrumental in pushing for extra mechanisms to help protect participant safety."

African advocates are following the trials conducted in their countries particularly closely, reported Manju Chatani, Coordinator of the African Microbicide Advocacy Group (AMAG). "Scientists scrutinized the data available on cellulose sulfate before the Phase III trials s
'"/>

Contact: Lori Heise
lheise@path.org
202-454-5028
AIDS Vaccine Advocacy Coalition (AVAC)
31-Jan-2007


Page: 1 2 3

Related medicine news :

1. Leading prevention researchers meeting in Washington, D.C., May 30-June 1, 2007
2. Leading European experts in magnetic resonance for animals
3. Leading healthcare authorities to address safety and effectiveness
4. Leading international osteoporosis experts to present at worlds largest osteoporosis congress
5. Leading hepatology textbook edited by SLU researchers
6. Leading groups offer NIH direct links to journals to make research access easy for public
7. Leading immunosuppressant CellCept significantly extends the lifespan of transplanted kidneys
8. Leading pediatricians group recommends infants sleep in cribs, not parents beds
9. Leading genomic technology expert to present Dickson Prize Lecture at Pitt
10. Leading experts discuss how to protect premature infants against RSV, a potentially dangerous virus
11. Leading sleep expert at Wake Forest to speak at NIH Consensus Conference

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2020)... LOUIS (PRWEB) , ... February 19, 2020 , ... ... the availability of and application deadline for its new Lifestyle Medicine Residency Curriculum ... designed for integrated implementation into medical residency programs. Driven by resident involvement, ...
(Date:2/19/2020)... ... 2020 , ... In 2017, the EU’s revamped Medical Device ... currently govern medical device manufacturers under the Medical Devices Directive (MDD); the timeline ... changes from the previous MDD include:, , Elimination of ...
(Date:2/19/2020)... ... February 19, 2020 , ... SEAL SHIELD, LLC - Almost a hundred ... infections (HAIs.) According to The Centers for Disease Control (CDC), 80% of infections are ... screens that are now acting as an extension of people’s hands, but not getting ...
(Date:2/16/2020)... ... February 16, 2020 , ... Canadian digital healthcare portal Ask The ... who are concerned about the Coronavirus. , "It is our duty and it is ... this deadly virus" said Prakash Chand, CEO of Ask The Doctor. , Doctors and ...
(Date:2/15/2020)... ... ... It all started back in 2010, when Jennifer Martinez (Founder) was delighted that ... on to something special. The Heartsters have now become a circle of friends ... condition or illness, a disability or just having a bad day. , “It ...
Breaking Medicine News(10 mins):
(Date:2/20/2020)... ... February 20, 2020 , ... PAINWeekEnd on March ... Arizona, will be a timely and relevant 2-day program providing busy clinicians and ... of chronic pain. , In 2020, paper prescriptions for certain painkillers have been ...
(Date:2/19/2020)... ... February 19, 2020 , ... Today, ... skilled nursing facility rehospitalization rate are the lowest in the company’s history. ... 29 percent drop year over year. GHC’s skilled nursing facility (SNF) rehospitalization rate ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... platform for research data management, has released a new SnapGene ... management features. With a ‘Quick View’ of supported DNA files, the molecular ...
Breaking Medicine Technology:
Cached News: